COX-2 Inhibitors After Cardiac Surgery - COX-2 Inhibitors After Cardiac Surgery

Description:

The goal of the trial was to evaluate the safety of the cyclooxygenase-2 (COX-2) inhibitors valdecoxib and its intravenous (IV) prodrug parecoxib compared with placebo for pain management following coronary artery bypass grafting (CABG).